导航癌症治疗诱导的心脏毒性:从病理生理学到治疗创新
Jessica Tetterton-Kellner1, Brian C Jensen2, Juliane Nguyen3
1Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Advanced drug delivery reviews
|June 20, 2024
概括
化疗可以导致心脏损伤 (心脏毒性),这是影响癌症幸存者的严重副作用. 目前的治疗方法有限,需要研究新的治疗策略和化学疗法诱导心脏毒性的药物治疗.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗和放射治疗是癌症的重要治疗方法,每年影响超过一百万美国患者.
- 心脏毒性或心脏损伤是癌症治疗的严重和潜在的长期不良影响.
- 目前化学疗法诱导的心脏毒性的治疗选择有限,德克斯拉佐克桑是FDA批准的唯一一种药物,用于抗环素诱导的病例,尽管它本身具有不良影响.
研究的目的:
- 审查化疗诱导心脏毒性的病理生理学.
- 讨论心脏毒性诊断方法和临床指南.
- 探索治疗和缓解策略,包括用于治疗开发的新药输送系统.
主要方法:
- 关于化疗诱导心脏毒性的现有研究的文献综述.
- 分析当前的诊断和治疗指南.
- 检查治疗干预的新兴药物输送技术.
主要成果:
- 化疗引起的心脏毒性呈现出各种不同的病理生理机制.
- 早期诊断和风险分层对于控制心脏毒性至关重要.
- 存在有限的治疗选择,突出显示了对先进药物输送系统的需求.
结论:
- 了解病理生理学和改进诊断方法是控制心脏毒性的关键.
- 开发新的治疗方法和向药物输送系统对于减轻化疗引起的心脏损伤至关重要.
- 对有效治疗方法的进一步研究对于改善癌症幸存者的长期结果至关重要.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
01:30Cancer Vaccines
352
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
352
01:26Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K